Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Roncarolo Maria Grazia, Director. Director active across 2 companies, notably Atara Biotherapeutics, Inc.. Aggregated, 5 disclosures have been recorded. History available since 8 June 2021. The latest transaction was disclosed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Maria Grazia Roncarolo serves as a Director at Atara Biotherapeutics, Inc. In this role, she contributes to the governance of the company and strategic decision-making. Roncarolo leverages her experience to help guide the company's policies and practices, ensuring compliance with regulations.